Drug:
Reaction: ECZEMA
20260101 - 20261231
No. 301 - 400
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 301 | 26892845 |
US |
27 | 2 |
Eczema, |
||||
DUPILUMAB, DUPILUMAB, PREDNISONE, |
||||
| 302 | 26893065 |
US |
34 | 2 |
Eczema, Erythema, Pruritus, |
||||
DUPILUMAB, |
||||
| 303 | 26893071 |
US |
52 | 2 |
Injection site urticaria, Asthma, Sinusitis, Urticaria, Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 304 | 26893105 |
US |
28 | 2 |
Eczema, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 305 | 26893107 |
US |
2 | |
Eczema, Injection site swelling, Injection site erythema, |
||||
DUPILUMAB, ALBUTEROL SULFATE, CETIRIZINE HYDROCHLORIDE, |
||||
| 306 | 26893510 |
EU |
51 | 1 |
Eczema, Enanthema, Lymphadenopathy, Mixed liver injury, |
||||
PANTOPRAZOLE, GABAPENTIN, DULOXETINE HYDROCHLORIDE, DULOXETINE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 307 | 26893825 |
US |
72 | 2 |
Dry skin, Skin lesion, Skin fissures, Pruritus, Skin exfoliation, Eczema, |
||||
DUPILUMAB, DUPILUMAB, CYANOCOBALAMIN, GABAPENTIN, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, NIFEDIPINE, DENOSUMAB, CYCLOSPORINE, SERTRALINE, SIMVASTATIN, ZOLPIDEM TARTRATE, |
||||
| 308 | 26893839 |
US |
26 | 1 |
Eczema, Rash, Injection site reaction, |
||||
DUPILUMAB, |
||||
| 309 | 26893867 |
US |
63 | 2 |
Feeling hot, Hot flush, Pruritus, Eczema, |
||||
DUPILUMAB, |
||||
| 310 | 26893873 |
US |
22 | 1 |
Eczema, |
||||
DUPILUMAB, CRISABOROLE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, CETIRIZINE HYDROCHLORIDE, |
||||
| 311 | 26894223 |
US |
2 | |
Eczema, Ocular hyperaemia, Pyrexia, Dyspnoea, Eye irritation, |
||||
DUPILUMAB, ACETAMINOPHEN, |
||||
| 312 | 26894230 |
US |
6 | 1 |
Eczema, Rash, Pruritus, Therapeutic response shortened, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 313 | 26894239 |
US |
54 | 2 |
Eczema, Drug ineffective, |
||||
TRALOKINUMAB-LDRM, |
||||
| 314 | 26894328 |
2 | ||
Eczema, Injection site bruising, |
||||
REPOSITORY CORTICOTROPIN, |
||||
| 315 | 26894893 |
US |
74 | 2 |
Injection site pain, Eczema, |
||||
DUPILUMAB, |
||||
| 316 | 26894923 |
US |
1 | |
Eczema, Therapeutic response decreased, |
||||
DUPILUMAB, |
||||
| 317 | 26894956 |
US |
64 | 1 |
Eczema, |
||||
DUPILUMAB, |
||||
| 318 | 26894969 |
US |
1 | 1 |
Eczema, Rash, Pruritus, |
||||
DUPILUMAB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, |
||||
| 319 | 26894979 |
MY |
50 | 1 |
Necrotising fasciitis, IgA nephropathy, Glucocorticoid deficiency, Debridement, Cellulitis, Fall, Swelling, Erythema, Pain in extremity, Viral infection, Eczema, Incorrect dose administered, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 320 | 26895280 |
US |
57 | |
Eczema, Pruritus, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 321 | 26895399 |
US |
28 | 1 |
Urticaria, Pruritus, Dry skin, Eczema, |
||||
DUPILUMAB, |
||||
| 322 | 26895434 |
US |
20 | 1 |
Fatigue, Eczema, Dry skin, Pruritus, Therapeutic response decreased, |
||||
DUPILUMAB, |
||||
| 323 | 26895780 |
US |
11 | 1 |
Eczema, |
||||
DUPILUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, |
||||
| 324 | 26896136 |
US |
52 | 2 |
Eczema, |
||||
DUPILUMAB, DUPILUMAB, SPIRONOLACTONE, |
||||
| 325 | 26896309 |
CA |
9 | 1 |
Anaphylactic reaction, Nausea, Headache, Chest pain, Haemoptysis, Urticaria, Asthma, Epistaxis, Dry skin, Cough, Eczema, Abdominal pain, Viral infection, Paraesthesia, Rhinorrhoea, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, LORAZEPAM, LORAZEPAM, ALBUTEROL SULFATE, ALBUTEROL, CICLESONIDE, |
||||
| 326 | 26896323 |
US |
1 | 1 |
Eczema, |
||||
DUPILUMAB, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 327 | 26896788 |
US |
57 | 2 |
Eczema, Therapeutic product effect decreased, |
||||
DUPILUMAB, |
||||
| 328 | 26896955 |
US |
16 | 2 |
Eczema, Erythema, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 329 | 26897187 |
US |
1 | |
Eczema, Pruritus, Skin exfoliation, Skin fissures, |
||||
DUPILUMAB, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, ALBUTEROL SULFATE, FLUTICASONE PROPIONATE AND SALMETEROL, |
||||
| 330 | 26886631 |
US |
5 | 1 |
Eczema, Pruritus, Scratch, Skin hyperpigmentation, Asthma, Cough, Skin burning sensation, |
||||
DUPILUMAB, |
||||
| 331 | 26886638 |
US |
2 | |
Eczema, Psoriasis, Drug ineffective, |
||||
DUPILUMAB, |
||||
| 332 | 26886802 |
US |
23 | 2 |
Eczema, Dermatitis atopic, Injection site reaction, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 333 | 26886816 |
US |
1 | 1 |
Eczema, Device use issue, |
||||
DUPILUMAB, |
||||
| 334 | 26886818 |
US |
1 | 1 |
Eczema, |
||||
DUPILUMAB, |
||||
| 335 | 26887031 |
US |
60 | 1 |
Colonoscopy, Gait disturbance, Spinal operation, Eczema, Intentional product misuse, Musculoskeletal disorder, Therapy interrupted, Eczema eyelids, Sensitivity to weather change, Psoriasis, |
||||
APREMILAST, APREMILAST, APREMILAST, |
||||
| 336 | 26887050 |
US |
29 | 2 |
Eczema, Eczema eyelids, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 337 | 26887071 |
US |
12 | 1 |
Eczema, Therapeutic response shortened, Erythema, Pruritus, Incorrect dose administered, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 338 | 26887603 |
US |
29 | 2 |
Eczema, Injection site pain, Drug ineffective, |
||||
LEBRIKIZUMAB-LBKZ, LEBRIKIZUMAB-LBKZ, |
||||
| 339 | 26887686 |
CA |
32 | 2 |
Abdominal pain, Anxiety, Asthma, Bacterial infection, Blood pressure increased, Cough, Decreased activity, Diarrhoea, Dizziness, Dyspnoea, Dyspnoea exertional, Ear infection, Eczema, Emphysema, Eosinophil count abnormal, Feeding disorder, Forced expiratory volume decreased, Full blood count abnormal, Fungal infection, Heart rate increased, Infection, Influenza, Loss of personal independence in daily activities, Malaise, Migraine, Middle insomnia, Musculoskeletal chest pain, Nasal congestion, Nasal discharge discolouration, Nasopharyngitis, Pneumonia, Obstructive airways disorder, Oropharyngeal pain, Pain, Productive cough, Psoriasis, Rales, Restrictive pulmonary disease, Rhinitis, Sinusitis, Sleep disorder, Sleep disorder due to a general medical condition, Stress, Tachycardia, Terminal insomnia, Tooth abscess, Upper-airway cough syndrome, Urinary tract infection, Urticaria, Vertigo, Vomiting, Wheezing, Drug ineffective, Therapeutic product effect decreased, Therapeutic response decreased, Product administration error, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, IPRATROPIUM BROMIDE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, MEPOLIZUMAB, OMALIZUMAB, |
||||
| 340 | 26887911 |
US |
77 | 2 |
Aphthous ulcer, Eczema, |
||||
DUPILUMAB, DUPILUMAB, HYDROCORTISONE, |
||||
| 341 | 26887913 |
US |
60 | 1 |
Eczema, Pruritus, Loss of personal independence in daily activities, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 342 | 26888213 |
US |
61 | 1 |
Photosensitivity reaction, Eczema, |
||||
DUPILUMAB, |
||||
| 343 | 26888539 |
US |
24 | 2 |
Eczema, |
||||
DUPILUMAB, |
||||
| 344 | 26888553 |
US |
2 | |
Eczema, Skin fissures, Rash, Therapeutic response shortened, Incorrect dose administered, |
||||
DUPILUMAB, |
||||
| 345 | 26888936 |
US |
11 | 1 |
Eczema, |
||||
DUPILUMAB, |
||||
| 346 | 26889346 |
US |
1 | |
Eczema, |
||||
DUPILUMAB, ALBUTEROL SULFATE, MOMETASONE FUROATE AND FORMOTEROL FUMARATE DIHYDRATE, NIACIN, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TERBINAFINE HYDROCHLORIDE, TERBINAFINE TABLETS 250 MG, FLUTICASONE PROPIONATE, |
||||
| 347 | 26889362 |
US |
2 | 1 |
Dry skin, Skin exfoliation, Eczema, Pruritus, Therapeutic response decreased, |
||||
DUPILUMAB, |
||||
| 348 | 26889786 |
US |
21 | 1 |
Eczema, Pruritus, Dry skin, |
||||
DUPILUMAB, |
||||
| 349 | 26890064 |
US |
25 | 1 |
Eczema, Skin discolouration, |
||||
DUPILUMAB, |
||||
| 350 | 26890319 |
US |
28 | 2 |
Eczema, Dry skin, Maternal exposure during pregnancy, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 351 | 26890333 |
US |
1 | |
Eczema, Pruritus, Peripheral swelling, Condition aggravated, |
||||
DUPILUMAB, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, MELOXICAM, ERGOCALCIFEROL, |
||||
| 352 | 26890343 |
US |
36 | 2 |
Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 353 | 26890600 |
US |
36 | 2 |
Eczema, |
||||
DUPILUMAB, |
||||
| 354 | 26891101 |
US |
40 | 2 |
Rash, Eczema, Skin exfoliation, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 355 | 26891757 |
US |
1 | |
Eczema, |
||||
DUPILUMAB, |
||||
| 356 | 26881250 |
US |
22 | 2 |
Dry eye, Eczema, Eye irritation, Pain, Ocular hyperaemia, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 357 | 26881252 |
US |
71 | 2 |
Eczema, Injection site pain, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 358 | 26881410 |
US |
63 | 1 |
Skin swelling, Skin ulcer, Dermatitis atopic, Eczema, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 359 | 26881419 |
US |
2 | |
Eczema, Dermatitis atopic, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, FEXOFENADINE HYDROCHLORIDE, IRON, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PIMECROLIMUS, ERGOCALCIFEROL, TAPINAROF, |
||||
| 360 | 26881445 |
US |
2 | |
Eczema, Skin fissures, Skin exfoliation, Dry skin, Sleep disorder due to a general medical condition, |
||||
DUPILUMAB, DEXTROAMPHETAMINE, DICYCLOMINE HYDROCHLORIDE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, FLUOXETINE HYDROCHLORIDE, NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE, LINACLOTIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 361 | 26881640 |
US |
2 | |
Alopecia, Eczema, |
||||
DUPILUMAB, |
||||
| 362 | 26881644 |
US |
77 | 2 |
Sleep disorder due to a general medical condition, Oral pain, Eczema, Eczematous cheilitis, Chapped lips, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 363 | 26881928 |
US |
37 | 2 |
Eczema, Incorrect dose administered, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 364 | 26882182 |
US |
68 | 2 |
Eczema, |
||||
DUPILUMAB, |
||||
| 365 | 26882201 |
US |
2 | |
Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 366 | 26882225 |
US |
38 | 1 |
Eczema, Inflammation, Pruritus, Irritability, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 367 | 26882238 |
US |
21 | 2 |
Injection site erythema, Injection site swelling, Eczema, Rash erythematous, Skin exfoliation, Eye pruritus, |
||||
DUPILUMAB, DUPILUMAB, DELGOCITINIB, |
||||
| 368 | 26882283 |
US |
||
Condition aggravated, Lacrimation increased, Skin exfoliation, Pain of skin, Skin burning sensation, Sensitive skin, Eczema, |
||||
LEBRIKIZUMAB-LBKZ, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, OIL, MINERAL OIL, |
||||
| 369 | 26882503 |
US |
28 | 2 |
Headache, Eczema, Erythema, Skin irritation, Oral herpes, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 370 | 26882574 |
US |
48 | |
Dermatitis atopic, Eczema, Product dose omission issue, Off label use, Intentional underdose, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
||||
| 371 | 26882852 |
JP |
85 | 1 |
Internal haemorrhage, Eczema, Oedema peripheral, |
||||
APALUTAMIDE, APALUTAMIDE, |
||||
| 372 | 26883181 |
US |
4 | 2 |
Injection site urticaria, Injection site erythema, Injection site warmth, Feeling hot, Eczema, |
||||
DUPILUMAB, DUPILUMAB, MAGNESIUM, |
||||
| 373 | 26883195 |
US |
72 | 2 |
Autoimmune disorder, Eczema, Rash macular, Hypersensitivity, |
||||
DUPILUMAB, TOCILIZUMAB, ROFLUMILAST, |
||||
| 374 | 26883212 |
US |
1 | |
Nail disorder, Eczema, |
||||
DUPILUMAB, |
||||
| 375 | 26884170 |
US |
||
Cutaneous T-cell lymphoma, Condition aggravated, Eczema, Dermatitis atopic, Pyrexia, Chills, Pain, Injury, Emotional distress, Anhedonia, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 376 | 26884188 |
US |
21 | 2 |
Eczema, Pruritus, Dry skin, |
||||
DUPILUMAB, |
||||
| 377 | 26884193 |
US |
85 | 2 |
Eczema, Emotional distress, Incorrect dose administered, |
||||
DUPILUMAB, |
||||
| 378 | 26884194 |
US |
5 | 1 |
Eczema, Pruritus, |
||||
DUPILUMAB, |
||||
| 379 | 26884350 |
JP |
2 | |
Autoimmune disorder, Paralysis, Dyspnoea, Gait disturbance, Mobility decreased, Brain fog, Feeling abnormal, Impaired quality of life, Eye pain, Ear pruritus, Nasal discomfort, Ear dryness, Throat irritation, Upper-airway cough syndrome, Oropharyngeal discomfort, Eczema, Pruritus, Poor quality sleep, Temperature regulation disorder, Paraesthesia, Lymph node pain, Insomnia, Pyrexia, Headache, Malaise, |
||||
METHOTREXATE, METHOTREXATE SODIUM, FOLIC ACID, |
||||
| 380 | 26884703 |
US |
72 | 2 |
Vision blurred, Eczema, Drug ineffective, |
||||
DUPILUMAB, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 381 | 26884979 |
US |
12 | 2 |
Eczema, |
||||
DUPILUMAB, CETIRIZINE HYDROCHLORIDE, |
||||
| 382 | 26885349 |
US |
||
Eczema, Foetal exposure during pregnancy, |
||||
ATOGEPANT, UBROGEPANT, |
||||
| 383 | 26885494 |
US |
6 | 2 |
Eczema, Pruritus, Skin hyperpigmentation, Skin burning sensation, Drug ineffective, Depressed mood, Anger, Scratch, |
||||
DUPILUMAB, |
||||
| 384 | 26885502 |
US |
50 | 2 |
Eczema, Pruritus, |
||||
DUPILUMAB, |
||||
| 385 | 26885503 |
US |
91 | 2 |
Device issue, Product dose omission issue, Eczema, Off label use, |
||||
GUSELKUMAB, GUSELKUMAB, |
||||
| 386 | 26885749 |
US |
1 | |
Dry skin, Skin fissures, Skin weeping, Skin haemorrhage, Pruritus, Eczema, Dry eye, Eye pruritus, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 387 | 26885962 |
US |
2 | |
Psoriasis, Eczema, Urticaria, |
||||
BIMEKIZUMAB, |
||||
| 388 | 26886108 |
US |
64 | 2 |
Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 389 | 26886205 |
US |
9 | 1 |
Pyrexia, Eczema, Blister, Tongue eruption, Cheilitis, |
||||
DUPILUMAB, |
||||
| 390 | 26886414 |
US |
7 | 1 |
Skin hyperpigmentation, Scratch, Skin burning sensation, Pruritus, Eczema, |
||||
DUPILUMAB, |
||||
| 391 | 26886506 |
GB |
||
Sepsis, Hidradenitis, Pneumonia, Mycobacterium tuberculosis complex test positive, Eczema, |
||||
USTEKINUMAB, |
||||
| 392 | 26876044 |
US |
27 | 2 |
Eczema, |
||||
DUPILUMAB, |
||||
| 393 | 26876046 |
US |
76 | 2 |
Eczema, Pruritus, Rash pruritic, Injection site pain, Foreign body sensation in eyes, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 394 | 26876213 |
US |
9 | 2 |
Eczema, |
||||
DUPILUMAB, |
||||
| 395 | 26876410 |
US |
16 | 1 |
Injection site pain, Injection site discomfort, Pruritus, Skin fissures, Dry skin, Injection site reaction, Eczema, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 396 | 26876425 |
CA |
21 | |
Eczema, Periorbital cellulitis, Staphylococcal infection, Herpes simplex, Inappropriate schedule of product administration, Overdose, Product dose omission issue, Intentional dose omission, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, AZATHIOPRINE, PANTOPRAZOLE, BUPROPION, |
||||
| 397 | 26876442 |
US |
1 | |
Blister, Stomatitis, Eczema, |
||||
DUPILUMAB, |
||||
| 398 | 26876637 |
US |
62 | 1 |
Injection site swelling, Injection site erythema, Injection site pain, Skin discolouration, Eczema, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 399 | 26876650 |
US |
2 | |
Eczema, |
||||
DUPILUMAB, |
||||
| 400 | 26876666 |
US |
2 | |
Hot flush, Cough, Throat irritation, Neuralgia, Cold flash, Eczema, Hypersensitivity, |
||||
SARILUMAB, CEFADROXIL, CICLOPIROX, CYANOCOBALAMIN, FAMOTIDINE, FOLIC ACID, GABAPENTIN, GABAPENTIN, HYDROCHLOROTHIAZIDE, IRBESARTAN, LEFLUNOMIDE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, MELOXICAM, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, PREDNISONE, ROSUVASTATIN CALCIUM, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30